Search - tctmd.com

Displaying 81 - 100 of 195

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

Presenter: Pravin Patil

September 25, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Advertisement

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Ticagrelor: Better Platelet Blockade Post-TAVR?

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content